(Q42597050)

3 November 2017

title

Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries (English)

1 reference

3 November 2017

P Ferrari

1

0 references

author name string

National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial12

series ordinal

2

1 reference

3 November 2017

publication date

11 September 2008

1 reference

Journal of Human Hypertension

3 November 2017

published in

1 reference

3 November 2017

volume

23

1 reference

3 November 2017

issue

3

1 reference

3 November 2017

page(s)

151-159

1 reference

https://scigraph.springernature.com/pub.10.1038/jhh.2008.117

3 November 2017

exact match

0 references

cites work

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Changes in antihypertensive therapy--the role of adverse effects and compliance

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Long-term persistence with antihypertensive drugs in new patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Aim, design and methods of the 'reasons for not intensifying antihypertensive treatment' (RIAT): an international registry in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Medication adherence and persistence as the cornerstone of effective antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Effect of terminal digit preference on blood pressure measurement and treatment in primary care

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

The impact of observer and patient factors on the occurrence of digit preference for zero in blood pressure measurement in a hypertension specialty clinic: evidence for the need of continued observation.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Why do GPs not implement evidence-based guidelines? A descriptive study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Blood pressure control and the implementation of guidelines in clinical practice: can we fill the gap?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Assessment of factors influencing blood pressure control in a managed care population

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.117

7 January 2021

Identifiers

DOI

10.1038/JHH.2008.117

1 reference

Dimensions Publication ID

3 November 2017

1046968992

0 references

1 reference